Your browser doesn't support javascript.
loading
Buffy coat signatures of breast cancer risk in a prospective cohort study.
Chung, Felicia Fei-Lei; Maldonado, Sandra González; Nemc, Amelie; Bouaoun, Liacine; Cahais, Vincent; Cuenin, Cyrille; Salle, Aurelie; Johnson, Theron; Ergüner, Bekir; Laplana, Marina; Datlinger, Paul; Jeschke, Jana; Weiderpass, Elisabete; Kristensen, Vessela; Delaloge, Suzette; Fuks, François; Risch, Angela; Ghantous, Akram; Plass, Christoph; Bock, Christoph; Kaaks, Rudolf; Herceg, Zdenko.
Affiliation
  • Chung FF; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France. feliciacfl@sunway.edu.my.
  • Maldonado SG; Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, 5, Jalan Universiti, Bandar Sunway, 47500, Subang Jaya, Selangor, Malaysia. feliciacfl@sunway.edu.my.
  • Nemc A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bouaoun L; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Cahais V; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France.
  • Cuenin C; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France.
  • Salle A; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France.
  • Johnson T; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France.
  • Ergüner B; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Laplana M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Datlinger P; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.
  • Jeschke J; Department of Basic Medical Sciences, University of Lleida, IRBLleida, 25198, Lleida, Spain.
  • Weiderpass E; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Kristensen V; Laboratory of Cancer Epigenetics, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Delaloge S; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France.
  • Fuks F; Faculty of Medicine, Institute for Clinical Epidemiology and Molecular Biology, University of Oslo, Oslo, Norway.
  • Risch A; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France.
  • Ghantous A; Laboratory of Cancer Epigenetics, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Plass C; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.
  • Bock C; Department of Biosciences and Medical Biology, Allergy-Cancer-BioNano Research Centre, University of Salzburg, 5020, Salzburg, Austria.
  • Kaaks R; Cancer Cluster Salzburg, Salzburg, Austria.
  • Herceg Z; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France.
Clin Epigenetics ; 15(1): 102, 2023 06 12.
Article in En | MEDLINE | ID: mdl-37309009
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Clin Epigenetics Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Clin Epigenetics Year: 2023 Document type: Article Affiliation country: